Home > PJ (current issue) > News / Daily News | Search

Return to PJ Online Home Page

The Pharmaceutical Journal
Vol 270 No 7243 p461-468
5 April 2003

News summary

Branch meetings   Future Events   Conferences

461 Labour to abolish Welsh script charge The Labour Party in Wales has promised that it will abolish prescription charges in the principality if it is returned to power in the National Assembly for Wales general election ...[more]

463 Atorvastatin reduces relative risk of heart attack by a third in hypertensives Atorvastatin reduces the relative risk of myocardial infarction by more than a third in patients with hypertension at moderate risk of developing cardiovascular events, researchers report. However, this large reduction corresponds with an absolute reduction in cardiovascular events of less than four events per 1,000 patient years...[more]

463 Target cholesterol values of <=5mmol/L are unrealistic Target serum cholesterol values of 5mmol/L or less may be unrealistic even for patients on the most efficacious lipid-lowering drugs, according to researchers from the Nottingham University...[more]

463 New medicines regulatory agency The Medicines and Healthcare Products Regulatory Agency (MHRA) was launched on 1 April. The agency has been formed from a merger of the Medicines Control Agency and the Medical Devices Agency...[more]

464 Placebo effect only for homoeopathic medicines used for childhood asthma Homoeopathic remedies are no better than placebo in improving the quality of life of children with mild to moderate asthma, a new study suggests...[more]

464 Contraceptive pill tops usage survey The contraceptive pill is the form of contraception most commonly used by women aged under 50 years, a survey shows...[more]

464 "Square" to produce guidelines on support for disabled students Research into improving provision for disabled pharmacy students is to be carried out at the School of Pharmacy, University of London...[more]

464 Link between length of oral contraceptive use and risk of cervical cancer confirmed A potential link between extended use of oral contraceptives and an increased risk of cervical cancer has been confirmed. However, more research is needed to establish the extent to which women remain at increased risk after they stop taking oral contraceptives...[more]

465 NSFs are driving prescribing costs to outstrip primary care budget increases National service frameworks are the main driver behind prescribing cost increases which outstrip primary care budget increases...[more]

465 Second wave of LPS pilots start New local pharmaceutical services (LPS) pilots have started in London and Manchester...[more]

465 Boots withdraws Wellbeing services Boots The Chemists has announced that it is to withdraw its Wellbeing services completely. The decision follows the discontinuation of some of the complementary health Wellbeing services in February this year...[more]

465 Consulting areas for Superdrug stores Superdrug is to introduce screened consulting areas to its stores following positive feedback from customers about the 20 stores that have private consulting rooms...[more]

466 Pharmacy promoted at Scottish Labour Party conference Community pharmacies were promoted as local walk-in centres to delegates at the recent Labour Party Scottish annual conference in Dundee...[more]

466 New NICE work schedule set out Treatments for coronary heart disease, cancer, dementia and eczema are just some of the drugs to be reviewed by the National Institute for Clinical Excellence (NICE)...[more]

466 Advice will cascade in event of terrorism Specific advice about what pharmacists should do in the event of a terrorist threat has not yet been issued at a national level...[more]

466 Better use of IT wins awards...[more]

466 NHS performance indicators...[more]

466 NPC set to expand...[more]

466 Welsh prescribing developments...[more]

466 MeReC update...[more]

466 Welsh complaints change...[more]

466 New Health Protection Agency...[more]

467 National body takes on NHS complaints Responsibility for reviewing complaints about National Health Service treatment or services is to be transferred from trusts to the Commission for Healthcare Audit and Improvement...[more]

467 Marketing scheme lifts sales for UniChem ales of non-prescription medicines at pharmacies that are members of UniChem's Community Pharmacy Initiative plus (CPI+) scheme have increased by more than 10 per cent in the past year, the company says...[more]

467 New drug treatment for hepatitis B Adefovir dipivoxil (Hepsera), a new treatment for chronic hepatitis B is being launched by Gilead Sciences...[more]

467 OFT fines Genzyme Genzyme Ltd has been fined £6.8m by the Office of Fair Trading for setting a price for Cerezyme (imiglucerase) that made competition from other suppliers impossible...[more]

467 Moxifloxacin launched...[more]

OFT report   American College of Cardiology congress   News in brief

OFT report news & related links (more)

461 Chancellor favours deregulation Whitehall sources have confirmed that the Chancellor of the Exchequer, Gordon Brown, is in favour of the Office of Fair Trading's recommendation to remove restrictions on National Health Service pharmacy services...[more]

461 Pharmacists urged to continue campaigning against the Office of Fair Trading’s call for deregulation Pharmacists should continue campaigning activity against the Office of Fair Trading's recommendation on deregulation, Hemant Patel, a member of the Royal Pharmaceutical Society's Council, told The Journal this week...[more]

462 Conflicting views expressed over Parliamentary responses to OFT report The National Pharmaceutical Association is disappointed with the Government's response to the Office of Fair Trading's recommendation on the regulation of community pharmacy...[more]

462 Customers worried about loss of pharmacies A new survey has revealed a high level of customer concern at the prospect of a reduced local pharmacy service...[more]


American College of Cardiology congressAmerican College of Cardiology congress more


468 ACE inhibitors are better than calcium channel blockers as first-line therapy Using angiotensin converting enzyme (ACE) inhibitors rather than calcium channel blockers (CCBs) to treat newly diagnosed hypertension in primary care gives better cardiovascular outcomes, according to research presented at the American College of Cardiology congress in Chicago...[more]

468 Heart failure after myocardial infarction gives poor prognosis Many patients develop heart failure (HF) or left ventricular systolic dysfunction (LVSD), or both, during their stay in hospital after a heart attack. They are four times more likely to die in hospital than patients who do not develop these complications, according to results presented at the American College of Cardiology congress in Chicago this week...[more]

468 Rosuvastatin beats other statins head-to-head Treatment with rosuvastatin (Crestor) gives greater reductions in low-density lipoprotein cholesterol (LDL-C) compared with three other statins in a parallel head-to-head trial...[more]

468 Long-term statins reduce anxiety ... and atrial fibrillation Long-term use of statins was associated with a reduced risk of anxiety, depression and hostility in 140 elderly patients who used statins continuously for an average of four years, compared with 219 patients who used them intermittently and 231 who did not use them...[more]


NEWS IN BRIEF

Diabetes service extended...[more]

Back to Top

  * PDF files on PJ Online require Acrobat Reader 4 or later.


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal